Profile for European Patent Office Patent: 4039253
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for European Patent Office Patent: 4039253
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| ⤷ Get Started Free | Feb 28, 2037 | Stemline Therap | ORSERDU | elacestrant hydrochloride |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
